BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34551074)

  • 1. Successful treatment and integrated genomic analysis of an infant with FIP1L1-RARA fusion-associated myeloid neoplasm.
    Miltiadous O; Petrova-Drus K; Kaicker S; Mathew S; Kluk M; Geyer JT; Rodriguez-Sanchez I; Bouvier N; Inghirami G; Stieglitz E; Khedoudja N; Benayed R; Richardson M; Anderson W; Benhamida J; You D; Londono D; Kung AL; Prockop SE; Roshal M; Zhang Y; Shukla N
    Blood Adv; 2022 Feb; 6(4):1137-1142. PubMed ID: 34551074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute promyelocytic leukemia with FIP1L1::RARA fusion gene: The clinical utility of transcriptome sequencing and bioinformatic analyses.
    Liu G; Long J; Chen Y; Li L; Huan X; Long P
    Front Oncol; 2022; 12():1049473. PubMed ID: 36776354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myeloid Sarcoma Type of Acute Promyelocytic Leukemia With a Cryptic Insertion of RARA Into FIP1L1: The Clinical Utility of NGS and Bioinformatic Analyses.
    Wang Y; Rui Y; Shen Y; Li J; Liu P; Lu Q; Fang Y
    Front Oncol; 2021; 11():688203. PubMed ID: 34249738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in patients with relapsed or refractory acute promyelocytic leukemia treated with or without autologous or allogeneic hematopoietic stem cell transplantation.
    Pemmaraju N; Tanaka MF; Ravandi F; Lin H; Baladandayuthapani V; Rondon G; Giralt SA; Chen J; Pierce S; Cortes J; Kantarjian H; Champlin RE; De Lima M; Qazilbash MH
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):485-92. PubMed ID: 23769669
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of Second Allogeneic Hematopoietic Cell Transplantation after Relapse of Myeloid Malignancies following Allogeneic Hematopoietic Cell Transplantation: A Retrospective Cohort on Behalf of the Grupo Español de Trasplante Hematopoyetico.
    Orti G; Sanz J; Bermudez A; Caballero D; Martinez C; Sierra J; Cabrera Marin JR; Espigado I; Solano C; Ferrà C; García-Noblejas A; Jimenez S; Sampol A; Yañez L; García-Gutiérrez V; Pascual MJ; Jurado M; Moraleda JM; Valcarcel D; Sanz MA; Carreras E; Duarte RF
    Biol Blood Marrow Transplant; 2016 Mar; 22(3):584-8. PubMed ID: 26631751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute myeloid leukemia or myelodysplastic syndrome with chromosome 17 abnormalities and long-term outcomes with or without hematopoietic stem cell transplantation.
    Britt A; Mohyuddin GR; McClune B; Singh A; Lin T; Ganguly S; Abhyankar S; Shune L; McGuirk J; Skikne B; Godwin A; Pessetto Z; Golem S; Divine C; Dias A
    Leuk Res; 2020 Aug; 95():106402. PubMed ID: 32590108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A rare case of acute promyelocytic leukemia with IRF2BP2-RARA fusion; and literature review.
    Liu Y; Xu F; Hu H; Wen J; Su J; Zhou Q; Qu W
    Onco Targets Ther; 2019; 12():6157-6163. PubMed ID: 31447564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Therapy-related myeloid neoplasms after successful treatment for acute promyelocytic leukemia: a report of four cases and literature review].
    Wang Z; Xu MZ; Chen YF; Xue F; Zhang L; Hu YM; Li CW; Li SZ; Wang JX; Mi YC
    Zhonghua Xue Ye Xue Za Zhi; 2019 Dec; 40(12):1008-1014. PubMed ID: 32023731
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytogenetic Evolution in Myeloid Neoplasms at Relapse after Allogeneic Hematopoietic Cell Transplantation: Association with Previous Chemotherapy and Effect on Survival.
    Ertz-Archambault N; Kosiorek H; Slack JL; Lonzo ML; Greipp PT; Khera N; Kelemen K
    Biol Blood Marrow Transplant; 2017 May; 23(5):782-789. PubMed ID: 28189903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with improved outcomes after second allogeneic hematopoietic cell transplantation for relapsed pediatric leukemia.
    Menon NN; Jenkins LM; Cui H; Jenkins C; Anwer F; Yeager AM; Katsanis E
    Ann Hematol; 2016 Mar; 95(4):637-44. PubMed ID: 26787415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal abnormality of acute promyelocytic leukemia other than
    Imataki O; Uemura M
    BMC Clin Pathol; 2016; 16():16. PubMed ID: 27708545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treosulfan, fludarabine, and 2-Gy total body irradiation followed by allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome and acute myeloid leukemia.
    Gyurkocza B; Gutman J; Nemecek ER; Bar M; Milano F; Ramakrishnan A; Scott B; Fang M; Wood B; Pagel JM; Baumgart J; Delaney C; Maziarz RT; Sandmaier BM; Estey EH; Appelbaum FR; Storer BE; Deeg HJ
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):549-55. PubMed ID: 24440648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Azacitidine for Relapse After Allogeneic Stem Cell Transplantation-Single-Center Study.
    Karakulska-Prystupiuk E; Drozd-Sokołowska J; Waszczuk-Gajda A; Stefaniak A; Dwilewicz-Trojaczek J; Kulikowska A; Chmarzyńska-Mróz E; Basak G; Paluszewska M; Boguradzki P; Jędrzejczak W
    Transplant Proc; 2018 Sep; 50(7):2212-2217. PubMed ID: 30177138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete response of myeloid sarcoma with FIP1L1-PDGFRA -associated myeloproliferative neoplasms to imatinib mesylate monotherapy.
    Tang TC; Chang H; Chuang WY
    Acta Haematol; 2012; 128(2):83-7. PubMed ID: 22722648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical features and treatment outcomes of pediatric acute promyelocytic leukemia in a Mexican pediatric hospital.
    Dorantes-Acosta E; Medina-Sanson A; Jaimes-García Y; López-Martínez B
    Rev Invest Clin; 2013; 65(5):392-8. PubMed ID: 24687338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical course of juvenile myelomonocytic leukemia in the blast crisis phase treated by acute myeloid leukemia-oriented chemotherapy and allogeneic hematopoietic stem cell transplantation.
    Ueda S; Sakata N; Muramatsu H; Sakaguchi H; Wang X; Xu Y; Kojima S; Yamaguchi T; Higa T; Takemura T
    Int J Hematol; 2014 Nov; 100(5):502-6. PubMed ID: 25047104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of RT-PCR PML-RARA transcript monitoring for extramedullary relapse of acute promyelocytic leukemia in the pleura, heart and pericardium after allogeneic SCT.
    Nasilowska-Adamska B; Majewski M; Seferynska I; Szczepinski A; Tomaszewska A; Prochorec-Sobieszek M; Guz K; Torbicki A; Warzocha K; Marianska B
    Ann Transplant; 2007; 12(3):33-8. PubMed ID: 18290568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic hematopoietic stem cell transplant in adult patients with myelodysplastic syndrome/myeloproliferative neoplasm (MDS/MPN) overlap syndromes.
    Sharma P; Shinde SS; Damlaj M; Hefazi Rorghabeh M; Hashmi SK; Litzow MR; Hogan WJ; Gangat N; Elliott MA; Al-Kali A; Tefferi A; Patnaik MM
    Leuk Lymphoma; 2017 Apr; 58(4):872-881. PubMed ID: 27687869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of hematopoietic stem cell transplantation in patients with myeloproliferative disease.
    Salit RB; Deeg HJ
    Hematol Oncol Clin North Am; 2014 Dec; 28(6):1023-35. PubMed ID: 25459177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
    Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.